Evidence map›Paper›PMID 30871537›Full record

ArticleBMC veterinary research2019

Antimicrobial use for selected diseases in cats in Switzerland.

K Schmitt, C Lehner, S Schuller, G Schüpbach-Regula, M Mevissen, R Peter, C R Müntener, H Naegeli, B Willi

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

K SchmittClinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.
C LehnerInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.
S SchullerDivision of Small Animal Internal Medicine, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
G Schüpbach-RegulaVeterinary Public Health Institute (VPHI), Vetsuisse Faculty, University of Bern, Bern, Switzerland.
M MevissenDivision of Pharmacology and Toxicology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
R PeterInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.
C R MüntenerInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland.
H NaegeliInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland. hanspeter.naegeli@vetpharm.uzh.ch.
B WilliClinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland. bwilli@vetclinics.uzh.ch.
University of Zurich · CHUniversity of Bern · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 407240_167054
6 · The paper itself

Abstract

backgroundAntibiotic use in human and veterinary medicine is considered a main driver of antimicrobial resistance. Although guidelines to promote appropriate use of antimicrobials in veterinary patients have been developed, antibiotic overprescription is assumed to be a common problem. The goal of this study was to investigate antimicrobial use in cats in Switzerland with acute upper respiratory tract disease (aURTD), feline lower urinary tract disease (FLUTD) and abscesses, and to assess compliance of prescription with consensus guidelines. A total of 776 cases (aURTD, n = 227; FLUTD, n = 333; abscesses, n = 216) presented to two university hospitals and 14 private veterinary practices in Switzerland during 2016 were retrospectively evaluated. Clinical history, diagnostic work-up and antimicrobial prescription (class, dosage, duration) were assessed.

resultsA total of 77% (aURTD), 60% (FLUTD) and 96% (abscesses) of the cases received antibiotic therapy; 13-24% received combination or serial therapy. The cats were treated for a median of 7 (abscesses) and 10 days (aURTD, FLUTD). Treatments with potentiated aminopenicillins (40-64%), third generation cephalosporins (25-28%), aminopenicillins (12-24%) and fluoroquinolones (3-13%) were most common. Prescriptions were judged in complete accordance with consensus guidelines in 22% (aURTD), 24% (FLUTD) and 17% (abscesses) of the cases. Antibiotics were prescribed although not indicated in 34% (aURTD), 14% (FLUTD) and 29% (abscesses) of the cases. The presence of lethargy, anorexia or fever in cats with aURTD, and the detection of bacteriuria in cats with FLUTD were significantly associated with antibiotic therapy. Although diagnostic work-up was significantly more common (aURTD: university hospitals, 58%; private practices, 1%; FLUTD: university hospitals, 92%; private practices, 27%) and the use of critically important antibiotics significantly less common at the university hospitals (aURTD, 10%; FLUTD, 14%) compared to private practices (aURTD, 38%; FLUTD, 54%), the frequency of antibiotic treatment was not different between the university hospitals and private practices.

conclusionsOur results indicate that overprescription of antibiotics in cats in Switzerland is common and accordance with guidelines is poor. The study highlights the need to promote antimicrobial stewardship in small animal medicine.

Indexed as

AbscessAnimalsAnti-Bacterial AgentsCat DiseasesCatsDrug UtilizationGuideline AdherenceHospitals, AnimalInappropriate PrescribingRespiratory Tract InfectionsSwitzerlandUrinary Tract InfectionsAnti-Bacterial AgentsAbscessAcute upper respiratory tract diseaseAntibiotic prescriptionAntimicrobial stewardshipFeline lower urinary tract diseaseFLUTDGuidelinesInfectionResistance

Identifiers

PMID30871537
PMCPMC6417182
OpenAlexW2936990493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.